Skip to main content
. Author manuscript; available in PMC: 2017 Nov 16.
Published in final edited form as: Cancer Prev Res (Phila). 2017 Jan 4;10(2):116–123. doi: 10.1158/1940-6207.CAPR-16-0232

Figure 6.

Figure 6

Immunohistochemical analysis of cyclin D1 in lung adenoma tissue. Adenomas from each treatment group (excluding the 1000 mg/kg/day metformin alone) from early and late stage interventions were analyzed via IHC for cyclin D1. No statistically significant differences in staining intensity or observed stained nuclei were detected after Kruskal Wallis testing.